{
    "Orphapacket": {
        "ORPHApacketId": "217085",
        "creationDate": "2020-06-27 22:10:58",
        "version": "1.3.6 / 4.1.7 [2020-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2020",
        "ORPHAcode": "217085",
        "Label": "Mucopolysaccharidosis type 2, severe form",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_217085",
        "DisorderType": {
            "value": "Clinical subtype",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377796"
        },
        "Synonyms": [
            {
                "Synonym": "Hunter syndrome type A"
            },
            {
                "Synonym": "Iduronate 2-sulfatase deficiency type A"
            },
            {
                "Synonym": "MPS2A"
            },
            {
                "Synonym": "MPSIIA"
            },
            {
                "Synonym": "Mucopolysaccharidosis type 2A"
            },
            {
                "Synonym": "Mucopolysaccharidosis type II, severe form"
            },
            {
                "Synonym": "Mucopolysaccharidosis type IIA"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "309900",
                "DisorderMappingRelation": "NTBT (ORPHA code's Narrower Term maps to a Broader Term)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Mucopolysaccharidosis type 2 (MPS2 see this term) severe form (MPS2S) is associated with a massive accumulation of glycosaminoglycans and a wide variety of symptoms including a rapidly progressive cognitive decline; it is most often fatal in the second or third decade."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "IDS",
                    "Name": "iduronate 2-sulfatase",
                    "ExternalReferences": [
                        {
                            "Source": "HGNC",
                            "Reference": "5389"
                        },
                        {
                            "Source": "OMIM",
                            "Reference": "300823"
                        }
                    ]
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "580",
                        "Label": "Mucopolysaccharidosis type 2"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "[EXPERT]_ORPHANET",
                    "PrevalenceType": "Prevalence at birth",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Childhood"
                }
            ]
        },
        "AverageAgeOfDeaths": {
            "AverageAgeOfDeath": [
                {
                    "value": "young Adult"
                }
            ]
        },
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "X-linked recessive"
                }
            ]
        }
    }
}